15 October 2024

Successful validation of capsid titer and host-cell derived DNA impurity assays extends our rAAV batch release QC portfolio

Read More

15 October 2024

Modular, scalable AAV purification process for safe vectors & recoveries of up to 50%

Read More

23 July 2024

Advancing AAV production with high-throughput screening and transcriptomics

Read More

20 May 2024

Combination of BMI, DLS and Visual Inspection to resolve particle formation issues in formulations commonly used in gene therapy

Read More

3 May 2024

Transcriptomic Analysis Identifies Differential Expression Patterns in Cellular Stress Response, Signal Transduction, and Extracellular Matrix Proteins During AAV Production

Read More

3 May 2024

Combination of BMI, DLS and Visual Inspection to Resolve Particle Formulation Issues in Formulations Commonly Used in Gene Therapy

Read More

3 May 2024

A Comprehensive ddPCR Portfolio for In-depth DNA Impurity Profiling

Read More

3 May 2024

Fit from Development to Manufacturing – A Successful rAAV9 Scalability Study in a suspension process using HEK293

Read More

3 May 2024

Impact of sample treatment on DNA length distribution analysis by duplex

Read More

3 May 2024

A Versatile Suspension-Based Platform for the Manufacturing of AAVs

Read More

3 May 2024

Impact of the Genome Length of Adeno-Associated Viral Vectors on Yield and Quality

Read More

3 May 2024

Manufacturing of a Broad Range of AAV Capsids Using our Suspension Platform

Read More